4

4Basebio PLC
LSE:4BB

Watchlist Manager
4Basebio PLC
LSE:4BB
Watchlist
Price: 590 GBX Market Closed
Market Cap: 91.7m GBX

4Basebio PLC
Investor Relations

4basebio Plc develops gene therapy technologies and solutions. The firm is engaged in developing next generation gene therapy technologies and solutions. The firm is focused on supplying therapeutic deoxyribonucleic (DNA) for gene therapies and DNA vaccines and also for providing solutions for delivery of the DNA based products to patients. The firm focuses to manufacture and supply synthetic DNA for research, therapeutic and pharmacological use. Its TruePrime DNA amplification technology is a primer free DNA amplification method using enzymes. Its Hermes is a non-viral delivery platform that can be used to deliver various payloads, ranging from DNA to small interfering ribonucleic acid (siRNA), as well as protein cargoes. The company also offers a messenger ribonucleic acid (mRNA) production service from the DNA template it makes. The company offers a range of services including production of synthetic DNA and RNA payloads, design and assembly of payloads in nanoparticles.

Show more
Loading
4BB
FTSE All Share Index
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Heikki Lanckriet Ph.D.
CEO, Chief Scientific Officer & Executive Director
No Bio Available
Mr. David Roth
CFO, Company Secretary & Executive Director
No Bio Available

Contacts

Address
CAMBRIDGE
25 Norman Way, Over
Contacts
+441223967943.0
www.4basebio.com
sparklesyt

See Also

Summary
4BB intrinsic value, competitors valuation, and company profile.
DCF Valuation
4BB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
4BB stock valuation using valuation multiples.
Wall Street Estimates
4BB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
4BB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.